Pulmonary aspergilloma and AIDS - A comparison of HIV-infected and HIV-negative individuals

被引:58
作者
AddrizzoHarris, DJ
Harkin, TJ
McGuinness, G
Naidich, DP
Rom, WN
机构
[1] NYU,MED CTR,DIV PULM & CRIT CARE MED,NEW YORK,NY 10016
[2] NYU,MED CTR,DEPT RADIOL,NEW YORK,NY 10016
[3] BELLEVUE HOSP CTR,CHEST SERV,NEW YORK,NY 10016
关键词
AIDS; aspergilloma; hemoptysis;
D O I
10.1378/chest.111.3.612
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective and methods: While pulmonary aspergilloma has been well described in immunocompetent hosts, to date and to our knowledge, there has not been a description of pulmonary aspergilloma in the HIV-infected individual. A retrospective review of cases seen by the Bellevue Hospital Chest Service from January 1992 through June 1995 identified 25 patients with aspergilloma. To investigate the impact of HIV status on pulmonary aspergilloma, we compared clinical presentation, progression of disease, treatment, and outcome in the HIV-infected patient vs the HIV-negative patient with aspergilloma. Results: Of the 25 patients identified, 10 were HIV-infected and 15 were HIV-negative. Predisposing diseases included tuberculosis (18/25, 72%), sarcoidosis (4/25, 16%), and Pneumocystis carinii pneumonia (3/25, 12%). All 25 patients had evidence of aspergilloma on chest CT. In addition, 17 of 25 patients had evidence of Aspergillus species in fungal culture, pathologic specimens, or immunoprecipitins. Hemoptysis was present in 15 of 25 (60%) (11/15 [73%] of the HIV-negative group vs 4/10 [40%] of the HIV-infected group). Severe hemoptysis (>150 mL/d) occurred in 5 of 15 (33%) of the HIV-negative group vs 1 of 10 (10%) of the HIV-infected group. Disease progression occurred more frequently among the HIV-infected group (4/8, 50% vs 1/13, 8% in HIV-negative individuals). All patients with disease progression had lymphocyte subset CD4+ <100 cells per microliter. Four of eight (50%) of the HIV-infected group vs 1 of 13 (8%) of the HIV-negative group died. Summary and conclusions: We conclude the following: (1) although tuberculosis and sarcoidosis are the most prevalent predisposing diseases, P carinii pneumonia in the HIV-infected individual is a risk factor for pulmonary aspergilloma; (2) HIV-infected individuals with CD4+ <100 cells per microliter are more likely to have disease progression despite treatment; and (3) HIV-negative patients are more likely to have hemoptysis requiring intervention.
引用
收藏
页码:612 / 618
页数:7
相关论文
共 50 条
  • [41] Greater diversity of HIV-1 quasispecies in HIV-infected individuals with active tuberculosis
    Collins, KR
    Mayanja-Kizza, H
    Sullivan, BA
    Quiñones-Mateu, ME
    Toossi, Z
    Arts, EJ
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 24 (05) : 408 - 417
  • [42] Oral manifestations in HIV-infected individuals from Thailand and Cambodia
    Reichart, PA
    Khongkhunthian, P
    Bendick, C
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2003, 192 (03) : 157 - 160
  • [43] Implementation of nutritional recommendations for HIV-infected individuals in black Africa
    Autoren, Weitere
    Winkler, Gertrud
    Kaptue, Lazare
    ERNAHRUNGS UMSCHAU, 2008, 55 (06): : 334 - 339
  • [44] Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors
    Périard, D
    Telenti, A
    Sudre, P
    Cheseaux, JJ
    Halfon, P
    Reymond, MJ
    Marcovina, SM
    Glauser, MP
    Nicod, P
    Darioli, R
    Mooser, V
    CIRCULATION, 1999, 100 (07) : 700 - 705
  • [45] Alkaline pH changes in the cerebellum of asymptomatic HIV-infected individuals
    Patton, HK
    Chu, WJ
    Hetherington, HP
    den Hollander, J
    Stewart, KE
    Raper, JL
    Shelton, BJ
    Benveniste, EN
    Benos, DJ
    NMR IN BIOMEDICINE, 2001, 14 (01) : 12 - 18
  • [46] Oral manifestations in HIV-infected individuals from Thailand and Cambodia
    P. A. Reichart
    P. Khongkhunthian
    C. Bendick
    Medical Microbiology and Immunology, 2003, 192 : 157 - 160
  • [47] PLASMA VIREMIA AS A MARKER OF VIRAL REPLICATION IN HIV-INFECTED INDIVIDUALS
    ESCAICH, S
    RITTER, J
    ROUGIER, P
    LEPOT, D
    LAMELIN, JP
    SEPETJAN, M
    TREPO, C
    AIDS, 1991, 5 (10) : 1189 - 1194
  • [48] Cancer Treatment Disparities in HIV-Infected Individuals in the United States
    Suneja, Gita
    Shiels, Meredith S.
    Angulo, Rory
    Copeland, Glenn E.
    Gonsalves, Lou
    Hakenewerth, Anne M.
    Macomber, Kathryn E.
    Melville, Sharon K.
    Engels, Eric A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (22) : 2344 - U228
  • [49] The long-term impact of HIV/AIDS on socio-economic status: a comparative analysis of households headed by HIV-positive and HIV-negative individuals in Western Kenya
    Ochieng, Benard Omondi
    Khagayi, Sammy
    Otieno, Moses
    Were, Joyce Akinyi
    Nyothach, Elizabeth Akinyi
    Hawi, Sarah
    Kwaro, Daniel
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2023, 35 (08): : 1107 - 1115
  • [50] Improvement in survival among HIV-infected individuals in the Republic of Korea: Need for an early HIV diagnosis
    Kee, Mee-Kyung
    Lee, Jin-Hee
    Kim, Eun-Jin
    Lee, Jiae
    Nam, Jeong-Gu
    Yoo, Byung-Hee
    Kim, Sung Soon
    BMC INFECTIOUS DISEASES, 2009, 9